Events and conferences 

As providers tackle new challenges that have arisen because of the COVID-19 pandemic, they are often still facing many underlying burdens while delivering care.

UPMC implemented a new technology in partnership with RxRevu, to enable its physicians to help patients lower prescription drug costs based upon their insurance coverage.

The leap from raising seed funding to landing a Series A was difficult for RxRevu CEO Carm Huntress, as it typically is for many in the digital health space.

As healthcare organizations actively think about cybersecurity and protecting themselves against cyber-attacks, it is more important than ever to focus on more than just technology and tools.

In the first five months of 2020, RxRevu hit a number of key milestones in the success of their SwiftRx Direct solution.

With so many people under- and unemployed because of the COVID-19 pandemic, the need for increased price transparency and reductions in patient costs is emphasized.

On May 20th, RxRevu and UCHealth leaders hosted a thought-provoking conversation about how price transparency tools are changing the way health systems manage the prescribing process.

COVID-19 has gotten the full attention of the world. As health systems adjust to tackle new challenges, they must also continue to plan for a largely unknown future.

Dr. Kevin O’Brien supports RxRevu as Chief Medical Officer, while continuing to work with patients in the specialty of Allergy, Asthma, and Immunology at Immunoe Health Centers in Colorado.

While most Americans know someone with diabetes, diabetics face certain challenges when searching and paying for care. New technology can alleviate some stress for this large portion of the population.